Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Hepatocurative effect of emblica officinalis on hepatotoxicity related to cytoch rome P-45O

A technology of therapeutic effect and hepatotoxicity, applied in the direction of medical preparations with non-active ingredients, medical preparations containing active ingredients, non-effective ingredients of polymer compounds, etc., can solve problems such as reversal of clinical parameters

Inactive Publication Date: 2005-06-15
COUNCIL OF SCI & IND RES
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, we believe that even in the absence of symptoms of genotoxicity, clinical parameters showing toxicity would be reversed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Hepatocurative effect of emblica officinalis on hepatotoxicity related to cytoch rome P-45O
  • Hepatocurative effect of emblica officinalis on hepatotoxicity related to cytoch rome P-45O
  • Hepatocurative effect of emblica officinalis on hepatotoxicity related to cytoch rome P-45O

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0022] Therefore, the present invention relates to a composition for treating liver diseases and its use in the treatment of drug-induced hepatotoxicity, said composition can counteract CYP 450 bioactivated hepatotoxicity caused by drugs, the composition contains emblica extract substances and optional pharmaceutical additives.

[0023] In one embodiment of the present invention, there is provided a composition for the treatment of liver diseases, the composition can counteract the hepatotoxicity of CYP 450 bioactivation caused by drugs, the composition contains extract of Amla emblica and optional medicinal additive.

[0024] In another embodiment of the present invention, the additive is selected from nutritional substances comprising protein, carbohydrate, sugar, talc, magnesium stearate, cellulose, calcium carbonate, starch-gelatin paste, etc., and / or Pharmaceutically acceptable carrier, excipient, diluent or solvent.

[0025] In yet another embodiment of the invention, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a composition useful for hepatocurative effect against CYP 450 bio-activation hepatoxoxicity induced by drugs, said composition comprising an extract from Emblica officinalis and optionally pharmaceutially acceptable additives and method of treating drug induced hepatotoxicity.

Description

technical field [0001] The present invention relates to a composition for treating liver diseases and its use in treating drug-induced liver toxicity, the composition can resist CYP 450 (cytochrome P-450) bioactivated liver toxicity caused by drugs, the The composition contains emblica extract and optional medicinal additives. Background technique [0002] Liver disease is still a major health hazard in urban and rural areas of the world. Despite scientific advances in our understanding of hepatotoxicity, and clues in this regard from the traditional system of medicine, we do not yet have effective pharmaceutical compositions for the treatment of liver diseases, especially those caused by various drugs. The Indian Council of Medical Research in New Delhi has included liver disease as one of six priority breakthrough areas for multidisciplinary research in its Traditional Medicines Research Programme, Revised Edition. [0003] Liver disease can be divided into acute or chro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/10A61K9/12A61K9/14A61K9/20A61K9/48A61K36/18A61K36/47A61K47/02A61K47/12A61K47/26A61K47/38A61K47/42A61P1/16A61P39/02A61P43/00
CPCA61K36/47A61P1/16A61P39/02A61P43/00A61K2300/00
Inventor 拉凯什·卡迈勒·约里谢赫·塔萨达克·阿卜杜拉库尔迪普·辛格德维得·库马尔·古普塔巴尔·克里尚·卡帕希迪利普·马尼克劳·蒙齐萨蒂德·莫汉·贾殷奥姆·帕卡什·苏里卡斯图里·拉尔·贝迪吴拉姆·纳比·卡齐
Owner COUNCIL OF SCI & IND RES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com